Stocks in Focus

SAMKEE CORP. Rises for Two Consecutive Days on Expectations of Expanded Humanoid Robot Parts Business [Featured Stock]

Shin Ha-yeon
2026-07-03 09:12:39
[Edaily Reporter Shin Ha-yeon ] SAMKEE CORP.(122350)has hit the daily price limit for two consecutive days.
According to MP Doctor on the 3rd, as of 9:08 a.m. that day, SAMKEE CORP. was trading at 2,345 won, up 29.99% from the previous trading day. This marks the second consecutive trading day that the stock has hit the daily price limit, following the previous day.
This is believed to have stimulated investor sentiment after the company announced on the 2nd that it would expand its robot parts portfolio to include pelvic and lower-body structures, starting with the supply of upper-body frames to a global humanoid robot company.
The company plans to first focus on supplying the initial batch of the humanoid upper-body frame currently under development. It aims to secure quality and productivity based on its aluminum die-casting technology and production capabilities, and then transition to a mass production supply system following prototype evaluation.
Subsequently, it will expand its business scope to include pelvic and lower-body structures, as well as leg frames. These components serve as core structural elements that support the load of humanoid robots, requiring high strength, lightweight design, and durability simultaneously. The company plans to secure a competitive edge by utilizing precision high-vacuum casting technology.
Previously, SAMKEE CORP. hit the daily price limit for three consecutive SamIl trading days starting on the 24th of last month following news that it had been selected as a developer of humanoid frames for a global robotics company.

Economy

Corporation

IT·Science

Economy

Online Banks’ Expansion of Loans to Borrowers with Medium-to-Low Credit Scores ‘Stalls’… Share of New Loans and Outstanding Balances Both Decline

The trend of three internet-only banks (KakaoBank Corp.(323410), Kbank, and Toss Bank) expanding credit loans to borrowers with medium-to-low credit scores has stalled. In the second quarter of this y…
2026-08-28 16:09:18

Corporation

SANIGEN Co., Ltd. Begins Full-Scale Development of New Drug Using “AI-Powered Endolysin to Combat Superbugs”

SANIGEN Co., Ltd.(188260), a company specializing in genome-based microbial diagnosis and control, has announced its leap toward becoming a global innovative biopharmaceutical company, spearheaded by …
2026-08-28 13:14:02

IT·Science

KGINICIS CO.,LTD. to Return Half of Net Profit to Shareholders… 50% Payout by 2030

KGINICIS CO.,LTD.(035600)will return 50% of its standalone adjusted net income to shareholders by 2030. The company has raised its shareholder return target from the previous 30% to 50% and extended t…
2026-08-28 17:22:28